Latham & Watkins LLP represented the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Design Therapeutics, Inc. Design Therapeutics, Inc. executed its initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Rapid7, Inc. (Nasdaq: RPD) announced the Rule 144A offering of $525 million principal amount of its 0.25% Convertible...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters in the transaction. Par Pacific Holdings, Inc. executed its underwritten public offering of 5,000,000 shares of its common stock...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters in the offering. Renewable Energy Group, Inc. (NASDAQ: REGI) executed its offering of an underwritten public offering of 5...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. Nurix Therapeutics, Inc. completed its follow-on offering of 5,175,000 shares...
You must be a Standard 1 Year member to access this content.
Simpson Thacher represented the underwriters in the offering. InnovAge Holding Corp. (“InnovAge”) completed the initial public offering of 16,666,667 shares of its common stock, which raised approximately...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. Heska Corporation executed its $175 million public offering of 940,860 shares...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the several underwriters in the offering. AVITA Medical, Inc. executed its follow-on offering of 3,214,250 shares of...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the underwriters on the offering. Certain selling shareholders of I-Mab issued $177 million SEC-registered follow-on secondary offering of 3,283,950 American depositary...
You must be a Standard 1 Year member to access this content.
Gornitzky represented the underwriters on the deal. Itamar Medical Ltd. completed a $79.8 million public offering of American Depositary Shares (ADSs) on the Nasdaq Capital Market....
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers and representatives of the underwriters in the offering. The $62 million initial public offering of 4,427,500 shares of common...
You must be a Standard 1 Year member to access this content.
